en
Scientific article
Open access
English

The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome

Published inEndocrine Connections, vol. 9, no. 6, p. 563-569
Publication date2020
Abstract

Context: Endothelial microparticles (EMPs) are novel, surrogate biomarkers of endothelial function and have been shown to be elevated in women with polycystic ovary syndrome (PCOS). It remains poorly understood how pharmacological options for managing PCOS affect EMP levels. Objective: To characterise and compare the effects of empagliflozin vs metformin on the circulating levels of EMPs in overweight/obese women with PCOS.

Keywords
  • SGLT2 inhibitors
  • Empagliflozin
  • Endothelial microparticles
  • Metformin
  • Polycystic ovary syndrome
Citation (ISO format)
JAVED, Zeeshan et al. The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome. In: Endocrine Connections, 2020, vol. 9, n° 6, p. 563–569. doi: 10.1530/EC-20-0173
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal2049-3614
140views
186downloads

Technical informations

Creation10/06/2020 12:49:00 PM
First validation10/06/2020 12:49:00 PM
Update time03/15/2023 10:56:57 PM
Status update03/15/2023 10:56:56 PM
Last indexation02/12/2024 1:20:06 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack